< Back to scientific publications

Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 2,175

An immunocompetent migrant presenting with neurosyphilis with an unusual unilateral papillitis: a case report

Authors: Turchetti P, Pacella F, Pacella E, Mirisola C, Uccella I.

Date: 2012

Scope of interest: infectious diseases


Read details
Magazine 15.26

ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease.

Authors: Montecchiani C, Pedace L, Lo Giudice T, Casella A, Mearini M, Gaudiello F, Pedroso JL, Terracciano C, Caltagirone C, et al

Date: 2016

Scope of interest: Neurogenetics


Read details
Report/Poster of Convention/Congress Act

Super-refractory state and new frontiers in epilepsy therapy

Authors: M. Fanella

Date: 2022

Scope of interest: Epilepsy/emergencies in neurology


Read details